You need Java to see this applet.

       " Welcome to Juno Research Patient Resources page".
    On this page you will find valuable information regarding the  process of drug
    development,  
    the importance that volunteer patients play on this process  some of the benefits that a
    volunteer receives for   participating in clinical trials and the opportunity to apply for any
    current  or upcoming clinical trials.

               THE PROCESS OF DRUG DEVELOPMENT

    The process of drug development consists of five main phases:
    The pre-clinical phase, phase I, Phase II, Phase III, and phase IV.Pre-clinical  

    Phase:
    This is the stage in which extensive laboratory research is conducted and the product or
    compound extensively tested in animals and human cells. This is a complicated process that
    takes several years of study and experimentation. Before any drug is used in humans, the
    pharmaceutical companies have to submit an application to the Food and Drug Administration
    (FDA), for evaluation and permission to begin testing in humans. The FDA  then evaluates all
    the data collected and submitted by the pharmaceutical company  and determines if the new-
    drug benefits  outweigh the risks. Based on the results of this evaluation, they either grant or
    denied the petition to start human testing.

    Phase One ( I ) : This phase mainly assess the safety of the new drug and investigates its
    side effects. It is the first time that the drug is tested in human subjects. It could last from a
    few weeks to several months. It is intended to determine what happens to the drug in the
    human body, how it is absorbed, metabolized, and excreted. This initial phase of human
          testing involves a limited number of healthy volunteers that usually ranges from 20 to 200
        
  patients

    Phase Two ( II ) : After it has been determined that the drug is safe, it is tested for efficacy
    on phase II trials. These trials may last from several months to a few years and involve several
    hundred volunteer patients that match specific criteria. Patients participating in phase II clinical
    studies are usually randomized to different treatments or arms. These arm treatments include
    the investigational drug, placebo or inactive drug, and other already-FDA-approved drugs to
    compare the effectiveness of the new drug. These studies are often “blinded”,meaning that
    neither the patients nor the research personnel will know to which arm treatment the patient
    have been assigned to.

    Phase Three ( III ) : Phase III clinical studies usually involves several thousand patients.
    These trials usually last from one to five years and are intended to further all knowledge of
    drug safety, effectiveness, side effects, and benefits in large scale populations. These trials
    use “randomized” and “blinded” parameters. After the trial is over and all information collected
    and analyzed, the pharmaceutical companies can then request approval from the FDA to
    market  the drug.

    Phase Four ( IV ) : Phase IV studies are post-marketing studies. In most cases the drug  has
    already been approved by the FDA and is available in most pharmacies. These trials may last
    several months and usually involve thousands of volunteers. They are used to further all
    knowledge of the drug, compare it to other drugs, and assess its long-term impact in the
    patient’s quality of life.

    VOLUNTEERS ROLL

    Patients volunteer all over the world to participate in clinical trials. They play a vital roll in the
    process of drug development, they are the real heroes of the process, they are the ones that
    make the difference and take that extra-step to go forward. All the medications that we find so
    readily today in the market are there thanks to millions of volunteers that successfully               
    completed clinical trials to better the world of other people. Other people that like them, were
    suffering from conditions that were taking a toll in their quality of life.

    VOLUNTEERS BENEFITS

    There are many benefits that volunteers receive while participating in a clinical study. Patients
    participating in clinical studies receive all study-related doctor visits, laboratory evaluations   
    and study medications at no charge for them. The Investigators are constantly checking on
    their condition and evaluating if the study is right for them, providing them with first class
    medical care, and most clinical studies offer monetary compensation for time and travel.
    Another benefit a volunteer receives from participating in a clinical study is the knowledge
          that their participation today may save and/or increase the quality of life of countless people
       
   in the  future, including those close to them.

    PARTICIPATING IN A CLINICAL STUDY

    Numerous clinical trials are developed each year. Juno Research is constantly looking and
    enrolling patients with the following conditions:  Diabetes, High Cholesterol, High Blood
    Pressure, Asthma, Allergies, Acute and Chronic Bronchitis, Arthritis, Sexual Dysfunction,
    Hepatitis, Urinary Incontinency, Overactive Bladder, Insomnia, Depression,Overweight, Lower
    Back Pain, Migraines, Angina, Peripheral Vascular Disease, GERD, Thyroid Problems, Chronic
    Anemia, etc.

    If you have any of these or other conditions and wish to participate  in a clinical study, please
    contact us at:

    Phone: (713) 779-5494

    Or email us at

      Patients@junoresearch.us

          A courteous representative will answer any questions you might have and offer more
          information about currently enrolling clinical trials.   
Juno Research,L.L.C
Delivering High Quality Results
Patients
Copyright© -2004-2011 Juno Research, L.L.C